Go Pro

Zai Lab (ZLAB) 10K Form and Latest SEC Filings 2026

Zai Lab logo
$19.12 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$19.15 +0.03 (+0.15%)
As of 07/2/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Zai Lab SEC Filings & Recent Activity

Zai Lab (NASDAQ:ZLAB) has submitted 480+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Zai Lab's financial statements. The most recent filing was a Form 144 submitted on June 30, 2026.

Form 4
Zai Lab Ltd Reports Ownership Change on Jun. 29, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Zai Lab Files Current Report on Jun. 17, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Zai Lab Files Quarterly Report on May. 7, 2026

The 10-Q contains Zai Lab's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Zai Lab SEC Filing History

Browse Zai Lab's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
06/30/2026 2:13 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 3:17 PM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2026 3:17 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2026 3:18 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2026 2:12 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2026 2:18 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2026 3:05 PM
Lis William (1574558) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2026 9:10 AM
Lis William (1574558) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2026 3:05 PM
Zai Lab (1704292) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2026 6:02 PM
TCG Crossover GP II, LLC (1969280) Filed by
Zai Lab (1704292) Subject
Form SCHEDULE 13G
06/08/2026 3:29 PM
Wang Yizhe (1884248) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2026 3:19 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2026 4:18 PM
Zai Lab (1704292) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2026 3:19 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2026 3:18 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2026 10:34 AM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2026 3:45 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2026 3:46 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2026 8:49 AM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2026 3:17 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2026 8:50 AM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2026 1:06 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2026 5:05 AM
Zai Lab (1704292) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2026 5:09 AM
Zai Lab (1704292) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2026 6:16 AM
Zai Lab (1704292) Filer
Form DEF 14A
04/28/2026 6:18 AM
Zai Lab (1704292) Filer
Form DEFA14A
04/28/2026 6:21 AM
Zai Lab (1704292) Filer
Form ARS
04/17/2026 6:12 AM
Zai Lab (1704292) Filer
Form PRE 14A
04/08/2026 6:33 PM
Amado Rafael (1662119) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2026 6:33 PM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2026 6:34 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2026 6:34 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2026 6:35 PM
Smiley Joshua L (1725189) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2026 5:54 PM
RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by
Zai Lab (1704292) Subject
Form SCHEDULE 13G
04/06/2026 2:11 PM
Amado Rafael (1662119) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/06/2026 2:15 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/06/2026 2:21 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/06/2026 2:26 PM
Smiley Joshua L (1725189) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/06/2026 2:04 PM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2026 4:57 PM
Amado Rafael (1662119) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 4:57 PM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
04/03/2026 4:58 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 4:58 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 4:59 PM
Smiley Joshua L (1725189) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2026 3:59 PM
Amado Rafael (1662119) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2026 3:20 PM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2026 3:05 PM
GAYNOR RICHARD (1741284) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2026 3:07 PM
Amado Rafael (1662119) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2026 3:08 PM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2026 3:08 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2026 3:09 PM
Smiley Joshua L (1725189) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 3:04 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2026 2:49 PM
Amado Rafael (1662119) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2026 2:50 PM
Smiley Joshua L (1725189) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2026 2:21 PM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2026 3:12 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2026 2:21 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2026 3:08 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2026 1:12 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2026 3:25 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 3:26 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 9:57 AM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2026 12:12 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2026 12:20 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2026 10:21 AM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2026 11:38 AM
Amado Rafael (1662119) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 6:04 AM
Zai Lab (1704292) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2026 6:08 AM
Zai Lab (1704292) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/17/2026 7:56 AM
RTW INVESTMENTS, LP (1493215) Filed by
Zai Lab (1704292) Subject
Form SCHEDULE 13G
02/13/2026 6:43 PM
Qiming Corporate GP IV, Ltd (1839126) Filed by
Zai Lab (1704292) Subject
Form SCHEDULE 13G/A
02/13/2026 4:32 PM
Capital World Investors (1422849) Filed by
Zai Lab (1704292) Subject
Form SCHEDULE 13G/A
02/10/2026 12:49 PM
WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by
Zai Lab (1704292) Subject
Form SCHEDULE 13G/A
02/05/2026 12:43 PM
FMR LLC (315066) Filed by
Zai Lab (1704292) Subject
Form SCHEDULE 13G/A
01/02/2026 3:15 PM
Amado Rafael (1662119) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 2:29 PM
Amado Rafael (1662119) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2025 3:34 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2025 9:47 AM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2025 3:42 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2025 3:11 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2025 8:43 AM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2025 7:35 AM
RTW INVESTMENTS, LP (1493215) Filed by
Zai Lab (1704292) Subject
Form SCHEDULE 13G/A
11/12/2025 8:33 AM
WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by
Zai Lab (1704292) Subject
Form SCHEDULE 13G
11/06/2025 6:04 AM
Zai Lab (1704292) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2025 6:06 AM
Zai Lab (1704292) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2025 10:49 AM
FMR LLC (315066) Filed by
Zai Lab (1704292) Subject
Form SCHEDULE 13G/A
11/03/2025 2:31 PM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/16/2025 3:05 PM
Zai Lab (1704292) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2025 2:36 PM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2025 3:32 PM
Smiley Joshua L (1725189) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2025 3:29 PM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2025 2:14 PM
Smiley Joshua L (1725189) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
08/18/2025 2:15 PM
Edmondson Frazor Titus III (1835780) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2025 2:21 PM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2025 9:24 AM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2025 4:22 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2025 7:14 AM
RTW INVESTMENTS, LP (1493215) Filed by
Zai Lab (1704292) Subject
Form SCHEDULE 13G
08/12/2025 3:45 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2025 3:45 PM
Du Ying (1731790) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025 3:45 PM
Chen Yajing (1985694) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025 3:45 PM
Amado Rafael (1662119) Reporting
Zai Lab (1704292) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Zai Lab SEC Filings - Frequently Asked Questions

Zai Lab (ZLAB) has submitted 480+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Zai Lab's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Zai Lab's financial statements page.

The most recent filing was a Form 144 submitted on June 30, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:ZLAB) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners